Experiences with
Fludarabine, cyclophosphamide and rituximab (FCR)866 public posts
Prediction of poor outcome in CLL patients following first-line treatment with FCR
New data from the German CLL8 trial a few years ago looks at factors that make patients at high risk to fail and progress early after treatment with FCR...
Full study...
http://www.nature.com/leu/journal/v27/n9/pdf/leu2013190a.pdf
Want to take advantage of all our features? Just log in!
or
Has anybody experienced or read about the problems of recurrent infections following FCR in spite of all blood test results being normal?
Having gone through the pain of FCR from August to December last year, I am now in remission with normal blood test results. However, I have suffered from recurrent infections, some more debilitating than others, since March.
What questions do you want Andrew Schorr of Patient Power to ask CLL world experts at the International Workshop on CLL?
Best Wishes, Andrew Schorr,
dx'ed 4/96, FCR in 2000, remaining in remission with with a second cancer in 2011, myelofibrosis, doing great with expensive little white pill morning and night.
How to Plan Your Long-Term CLL Treatment Journey - Patient Power - Professor Peter Hillmen
v=rIM6SsUVmxA
Is FCR for CLL Treatment Outdated? The Pros and Cons - See more at: http://www.patientpower.info/bio/peter-hillmen-md-phd#sthash.rLwRn62b.dpuf -
http://www.youtube.com/watch?
CLL - a Cancer of the Immune System
been treated with a CD20 monoclonal antibody such as Rituximab/Rituxan/Mabthera, Obinutuzumab/Gazyva or Ofatumumab/Arzerra within the last year, where you may be experiencing Late Onset Neutropenia https://healthunlocked.com/cllsupport/posts/130895083/late-onset-neutropenia-may-be-a-complication-of-fcr
Chemo brain research shows promise of finding answers - and some help
articles.view/articleNo/34848/title/After-Chemo/
Some of the reported research includes long term studies into children given chemotherapy for ALL and in the animal studies, one of the chemo drugs that was found to adversely affect rodents was cyclophosphamide, the "C" in FCR.